Skip to main content

Illumina, Esoterix


Illumina has lowered the price of its Oligator oligo-synthesis technology to $.11 per base from $.16 per base, the company said last week. The new pricing schedule will affect labs “consuming large volumes” of oligonucleotides, Illumina said, although the company did not elaborate further. The Oligator technology, which is used in genotyping, sequencing, gene-expression analysis, and PCR, can produce more than 3,000 oligos at a time, according to the company.

Esoterix has launched a new hepatitis C assay, the HCVExact, which measures virus levels in HCV patients. The assay uses the TaqMan real-time PCR. The company has also released a mutation-anal-ysis test for cystic fibrosis screening. This test, the CFDetx, includes the 25 mutations recommended by both the American College of Medical Genetics and the American College of Obstetricians and Gynecologists for inclusion in HCV assays, Eso-terix said.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.